Skip to content

A study to compare effects of two drugs dexmeditomidine and fentanyl on blood pressure, pulse and recovery from general anesthesia in patients undergoing Ear Nose or throat surgery.

A randomizrd double blind clinical trial to compare dexmedetomidine with fentanyl as an anesthetic adjuvant in patients undergoing ENT surgery. - Nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/07/006053
Enrollment
60
Registered
2015-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA Class 1&2 patients scheduled for elective ENT surgeries.

Interventions

Intervention1: GROUP D (DEXMEDITOMIDINE): Bolus dose of dexmeditomidine 1 micrograms/kg body weight i.v over 10 minutes followed by infusion of dexmeditomidine 0.6 micrograms/kg/hr. Control Interventi

Sponsors

Dr Rohit Kaushikbhai Patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A) ASA class 1&2 scheduled for elective surgeries. B) age between 18 & 60 years. C) no history of alcohol or drug abuse. D) not received any opioid analgesic or alpha 2 agonist 24 hours prior to surgery.

Exclusion criteria

Exclusion criteria: A)history of allergy to alpha agonist or sulpha drug. B)pregnant, lactating mothers and morbidly obese patients. C)heart block. D)presence of clinically significant neurologic, cardiac,renal,hepatic,gastrointestinal endocrine disease.

Design outcomes

Primary

MeasureTime frame
To Study and compare the effects of dexmedetomidine with fentanyl for 1) The sympatholytic effects & intraoperative hemodynamics. 2) Reduction in intraoperative propofol requirement. 3) The recovery variables.Timepoint: Heamodynamics parameters observed intraoperatively and recovery variables during extubation.

Secondary

MeasureTime frame
To compare analgesic sparing effects and postoperative nausea and vomiting of dexmedetomidine with fentanyl.Timepoint: Secondary outcome observed after extubation for one hour.

Countries

India

Contacts

Public ContactDr Rohit kaushikbhai patel

Government medical college surat

harshapad@yahoo.com9925176299

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026